Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toon Van Gorp

Showing results (41-50 of 168) with videos related to

Pageof 17
Sort By:
British Journal of Cancer|April 4, 2026
Value of whole-body diffusion-weighted MRI for the prediction of surgical and clinical outcome after neoadjuvant chemotherapy in advanced ovarian cancerVincent Vandecaveye, Raphaëla C Dresen, Thaïs Baert, et al.
Journal of Ovarian Research|May 30, 2014
Preoperative HE4 and ROMA values do not improve the CA125 diagnostic value for borderline tumors of the ovary (BOT) - a study of the TOC ConsortiumElena Ioana Braicu, Toon Van Gorp, Mani Nassir, et al.
International Journal of Molecular Sciences|October 16, 2024
Association of the Single Nucleotide Polymorphisms rs11556218, rs4778889, rs4072111, and rs1131445 of the Interleukin-16 Gene with Ovarian CancerRafał Watrowski, Eva Schuster, Toon Van Gorp, et al.
Expert Review of Molecular Diagnostics|February 24, 2015
Natural history of high-grade cervical intraepithelial neoplasia: a review of prognostic biomarkersMargot M Koeneman, Roy F P M Kruitwagen, Hans W Nijman, et al.
Gynecologic Oncology|June 2, 2024
Antitumor activity and safety of the PD-1 inhibitor retifanlimab in patients with recurrent microsatellite instability-high or deficient mismatch repair endometrial cancer: Final safety and efficacy results from cohort H of the POD1UM-101 phase I studyDominique Berton, Patricia Pautier, Domenica Lorusso, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 22, 2016
Correspondence: Premature Stop of the SOCceR Trial, a Multicenter Randomized Controlled Trial on Secondary Cytoreductive Surgery: Netherlands Trial Register Number: NTR3337Rafli van de Laar, Roy F P M Kruitwagen, Petra L M Zusterzeel, et al.
BMC Cancer|January 24, 2008
Expression profiling to predict the clinical behaviour of ovarian cancer fails independent evaluationOlivier Gevaert, Frank De Smet, Toon Van Gorp, et al.
Journal of Contemporary Brachytherapy|August 10, 2016
Predictive criteria for MRI-based evaluation of response both during and after radiotherapy for cervical cancerJordy Mongula, Brigitte Slangen, Doenja Lambregts, et al.
Cells|January 11, 2024
A Microfluidics Approach for Ovarian Cancer Immune Monitoring in an Outpatient SettingSarah Libbrecht, Ann Vankerckhoven, Koen de Wijs, et al.
Gynecologic Oncology|January 31, 2013
A comparison between an ultrasound based prediction model (LR2) and the risk of ovarian malignancy algorithm (ROMA) to assess the risk of malignancy in women with an adnexal massJeroen Kaijser, Toon Van Gorp, Kirsten Van Hoorde, et al.
Pageof 17

Showing results (41-50 of 168) with videos related to

Sort By:
Pageof 17
British Journal of Cancer|April 4, 2026
Value of whole-body diffusion-weighted MRI for the prediction of surgical and clinical outcome after neoadjuvant chemotherapy in advanced ovarian cancerVincent Vandecaveye, Raphaëla C Dresen, Thaïs Baert, et al.
Journal of Ovarian Research|May 30, 2014
Preoperative HE4 and ROMA values do not improve the CA125 diagnostic value for borderline tumors of the ovary (BOT) - a study of the TOC ConsortiumElena Ioana Braicu, Toon Van Gorp, Mani Nassir, et al.
International Journal of Molecular Sciences|October 16, 2024
Association of the Single Nucleotide Polymorphisms rs11556218, rs4778889, rs4072111, and rs1131445 of the Interleukin-16 Gene with Ovarian CancerRafał Watrowski, Eva Schuster, Toon Van Gorp, et al.
Expert Review of Molecular Diagnostics|February 24, 2015
Natural history of high-grade cervical intraepithelial neoplasia: a review of prognostic biomarkersMargot M Koeneman, Roy F P M Kruitwagen, Hans W Nijman, et al.
Gynecologic Oncology|June 2, 2024
Antitumor activity and safety of the PD-1 inhibitor retifanlimab in patients with recurrent microsatellite instability-high or deficient mismatch repair endometrial cancer: Final safety and efficacy results from cohort H of the POD1UM-101 phase I studyDominique Berton, Patricia Pautier, Domenica Lorusso, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 22, 2016
Correspondence: Premature Stop of the SOCceR Trial, a Multicenter Randomized Controlled Trial on Secondary Cytoreductive Surgery: Netherlands Trial Register Number: NTR3337Rafli van de Laar, Roy F P M Kruitwagen, Petra L M Zusterzeel, et al.
BMC Cancer|January 24, 2008
Expression profiling to predict the clinical behaviour of ovarian cancer fails independent evaluationOlivier Gevaert, Frank De Smet, Toon Van Gorp, et al.
Journal of Contemporary Brachytherapy|August 10, 2016
Predictive criteria for MRI-based evaluation of response both during and after radiotherapy for cervical cancerJordy Mongula, Brigitte Slangen, Doenja Lambregts, et al.
Cells|January 11, 2024
A Microfluidics Approach for Ovarian Cancer Immune Monitoring in an Outpatient SettingSarah Libbrecht, Ann Vankerckhoven, Koen de Wijs, et al.
Gynecologic Oncology|January 31, 2013
A comparison between an ultrasound based prediction model (LR2) and the risk of ovarian malignancy algorithm (ROMA) to assess the risk of malignancy in women with an adnexal massJeroen Kaijser, Toon Van Gorp, Kirsten Van Hoorde, et al.
Pageof 17